Runcaciguat
A pharmaceutical drug used in the treatment of chronic kidney disease
| Runcaciguat | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Runcaciguat is a pharmaceutical compound that acts as a soluble guanylate cyclase (sGC) activator. It is primarily under investigation for its potential therapeutic effects in treating chronic kidney disease (CKD) and other related conditions.
Mechanism of Action[edit | edit source]
Runcaciguat functions by directly stimulating the enzyme soluble guanylate cyclase, which is a key component in the nitric oxide (NO) signaling pathway. This pathway is crucial for various physiological processes, including vasodilation and regulation of blood pressure. By activating sGC, runcaciguat increases the levels of cyclic guanosine monophosphate (cGMP), leading to vasodilation and improved blood flow, which can be beneficial in conditions like CKD where blood flow to the kidneys is compromised.
Clinical Development[edit | edit source]
Runcaciguat is currently undergoing clinical trials to evaluate its efficacy and safety in patients with chronic kidney disease. The drug is being studied for its potential to slow the progression of CKD and improve renal function by enhancing blood flow and reducing oxidative stress in the kidneys.
Potential Benefits[edit | edit source]
The activation of sGC by runcaciguat may offer several benefits in the management of CKD:
- Improved Renal Blood Flow: By promoting vasodilation, runcaciguat can enhance blood flow to the kidneys, potentially improving kidney function.
- Reduction of Oxidative Stress: Increased cGMP levels can help reduce oxidative stress, which is a contributing factor in the progression of CKD.
- Blood Pressure Regulation: As a vasodilator, runcaciguat may aid in the management of hypertension, a common comorbidity in CKD patients.
Side Effects and Safety[edit | edit source]
As with any pharmaceutical agent, runcaciguat may have side effects. Commonly reported side effects in clinical trials include headache, dizziness, and hypotension. The safety profile of runcaciguat is still being evaluated in ongoing studies.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
